| __timestamp | Opthea Limited | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 3401685 | 15411924 |
| Thursday, January 1, 2015 | 4284228 | 22593274 |
| Friday, January 1, 2016 | 3581295 | 33173050 |
| Sunday, January 1, 2017 | 4838300 | 62224159 |
| Monday, January 1, 2018 | 24891534 | 95607434 |
| Tuesday, January 1, 2019 | 31347891 | 221269028 |
| Wednesday, January 1, 2020 | 17480747 | 400745069 |
| Friday, January 1, 2021 | 34710152 | 580520000 |
| Saturday, January 1, 2022 | 108459978 | 663366000 |
| Sunday, January 1, 2023 | 181563523 | 755113687 |
| Monday, January 1, 2024 | 176326321 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is the lifeblood of success. Argenx SE and Opthea Limited, two prominent players, have been making significant strides in research and development (R&D) over the past decade. From 2014 to 2023, Argenx SE has consistently outpaced Opthea Limited in R&D spending, with a staggering 1,000% increase, peaking at 755 million in 2023. In contrast, Opthea Limited's R&D expenses grew by approximately 5,200%, reaching 182 million in the same year. This trend highlights Argenx SE's aggressive investment strategy, which could be a key driver of its innovative breakthroughs. However, Opthea's recent surge in R&D spending suggests a strategic pivot towards more robust innovation efforts. As we look to the future, the biotech landscape will be shaped by how these companies leverage their R&D investments to bring groundbreaking therapies to market.
Comparing Innovation Spending: Eli Lilly and Company and Opthea Limited
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
argenx SE or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
argenx SE vs Halozyme Therapeutics, Inc.: Strategic Focus on R&D Spending
argenx SE or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
Blueprint Medicines Corporation vs Opthea Limited: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Opthea Limited vs Veracyte, Inc.